
Brenda Libby Coleman
Examiner (ID: 13884, Phone: (571)272-0665 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1967 |
| Pending Applications | 488 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14359951
[patent_doc_number] => 10301262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
[patent_app_type] => utility
[patent_app_number] => 15/738175
[patent_app_country] => US
[patent_app_date] => 2016-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 29
[patent_no_of_words] => 43779
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/738175 | Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders | Jun 20, 2016 | Issued |
Array
(
[id] => 13944491
[patent_doc_number] => 10208001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Process for preparing 1,4-dibenzodiazepines via Buchwald-Hartwig chemistry
[patent_app_type] => utility
[patent_app_number] => 15/565589
[patent_app_country] => US
[patent_app_date] => 2016-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2868
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565589
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565589 | Process for preparing 1,4-dibenzodiazepines via Buchwald-Hartwig chemistry | Jun 20, 2016 | Issued |
Array
(
[id] => 14794015
[patent_doc_number] => 10400000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/735372
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 16040
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735372
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/735372 | Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof | Jun 12, 2016 | Issued |
Array
(
[id] => 16276725
[patent_doc_number] => 10759739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => P62-ZZ small molecule modulators
[patent_app_type] => utility
[patent_app_number] => 15/580643
[patent_app_country] => US
[patent_app_date] => 2016-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10027
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580643 | P62-ZZ small molecule modulators | Jun 6, 2016 | Issued |
Array
(
[id] => 14171575
[patent_doc_number] => 10259782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => ROR gamma (RORg) modulators
[patent_app_type] => utility
[patent_app_number] => 15/579143
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6361
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 479
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579143
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579143 | ROR gamma (RORg) modulators | Jun 2, 2016 | Issued |
Array
(
[id] => 15008421
[patent_doc_number] => 10450326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Thiazolopyrimidinone compounds and preparation methods and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/577725
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 10687
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577725
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577725 | Thiazolopyrimidinone compounds and preparation methods and use thereof | Jun 2, 2016 | Issued |
Array
(
[id] => 14611527
[patent_doc_number] => 10358449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Xanthine derivative
[patent_app_type] => utility
[patent_app_number] => 15/577946
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5134
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577946
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577946 | Xanthine derivative | May 25, 2016 | Issued |
Array
(
[id] => 11901908
[patent_doc_number] => 09771332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => '2-thiopyrimidinones'
[patent_app_type] => utility
[patent_app_number] => 15/144234
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14349
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144234
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144234 | 2-thiopyrimidinones | May 1, 2016 | Issued |
Array
(
[id] => 15466087
[patent_doc_number] => 10548897
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => KSR antagonists
[patent_app_type] => utility
[patent_app_number] => 15/566565
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 26
[patent_no_of_words] => 23519
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566565
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566565 | KSR antagonists | Apr 14, 2016 | Issued |
Array
(
[id] => 14485059
[patent_doc_number] => 10329296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Indole derivatives
[patent_app_type] => utility
[patent_app_number] => 15/563259
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16112
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563259
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563259 | Indole derivatives | Apr 13, 2016 | Issued |
Array
(
[id] => 12837238
[patent_doc_number] => 20180170919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => CRYSTALINE FORMS OF N-[6-(CIS-2,6-DIMETHYLMORPHOLINE -4-YL)PYRIDINE-3-YL]-2-METHYL-4'-(TRIFLUOROMETHOXY) [1,1'-BIPHENYL]-3-METHANAMIDE MONOPHOSPHATE, AND PROCESS OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/579881
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579881
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579881 | Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4'-(trifluoromethoxy) [1,1'-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof | Mar 29, 2016 | Issued |
Array
(
[id] => 11083736
[patent_doc_number] => 20160280701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'INHIBITORS OF COLLAGEN PROLYL 4-HYDROXYLASE'
[patent_app_type] => utility
[patent_app_number] => 15/082372
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 31397
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082372
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/082372 | Inhibitors of collagen prolyl 4-hydroxylase | Mar 27, 2016 | Issued |
Array
(
[id] => 12680653
[patent_doc_number] => 20180118717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => Substituted Quinazoline Derivatives as DNA Methyltransferase Inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/560883
[patent_app_country] => US
[patent_app_date] => 2016-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560883
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560883 | Substituted quinazoline derivatives as DNA methyltransferase inhibitors | Mar 24, 2016 | Issued |
Array
(
[id] => 13942343
[patent_doc_number] => 10206916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Cabozantinib salts and their use as anti-cancer agents
[patent_app_type] => utility
[patent_app_number] => 15/560519
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8779
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560519
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560519 | Cabozantinib salts and their use as anti-cancer agents | Mar 21, 2016 | Issued |
Array
(
[id] => 11003771
[patent_doc_number] => 20160200721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'AROMATIC HETEROCYCLYLAMINE DERIVATIVE HAVING TRPV4-INHIBITING ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/076728
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24628
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15076728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/076728 | Aromatic heterocyclylamine derivative having TRPV4-inhibiting activity | Mar 21, 2016 | Issued |
Array
(
[id] => 11003771
[patent_doc_number] => 20160200721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'AROMATIC HETEROCYCLYLAMINE DERIVATIVE HAVING TRPV4-INHIBITING ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/076728
[patent_app_country] => US
[patent_app_date] => 2016-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24628
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15076728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/076728 | Aromatic heterocyclylamine derivative having TRPV4-inhibiting activity | Mar 21, 2016 | Issued |
Array
(
[id] => 11107518
[patent_doc_number] => 20160304489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide'
[patent_app_type] => utility
[patent_app_number] => 15/073766
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18548
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15073766
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/073766 | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide | Mar 17, 2016 | Issued |
Array
(
[id] => 14171641
[patent_doc_number] => 10259815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Gabaergic ligands and their uses
[patent_app_type] => utility
[patent_app_number] => 15/560002
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 27
[patent_no_of_words] => 24651
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560002
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560002 | Gabaergic ligands and their uses | Mar 17, 2016 | Issued |
Array
(
[id] => 12239822
[patent_doc_number] => 20180072685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'METHOD FOR PRODUCING (4S)-4-[4-CYANO-2-(METHYLSULFONYL)PHENYL]-3,6-DIMETHYL-2-OXO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,3,4-TETRAHYDRO PYRIMIDINE-5-CARBONITRILE'
[patent_app_type] => utility
[patent_app_number] => 15/559385
[patent_app_country] => US
[patent_app_date] => 2016-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11750
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559385
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559385 | Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile | Mar 14, 2016 | Issued |
Array
(
[id] => 12233104
[patent_doc_number] => 20180065966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'Antimicrobial Compounds And Methods Of Making And Using The Same'
[patent_app_type] => utility
[patent_app_number] => 15/557007
[patent_app_country] => US
[patent_app_date] => 2016-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54205
[patent_no_of_claims] => 129
[patent_no_of_ind_claims] => 85
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557007 | Antimicrobial compounds and methods of making and using the same | Mar 10, 2016 | Issued |